Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

In vitro effects of interleukin-12 on the growth of blast progenitors in acute myelogenous leukemia

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Trinchieri G, Scott P . Interleukin-12: basic principles and clinical applications Curr Top Microbiol Immunol 1999 238: 57–78

    CAS  PubMed  Google Scholar 

  2. Lee SM, Suen Y, Qian J, Knoppel E, Cairo MS . The regulation and biological activity of interleukin 12 Leuk Lymphoma 1998 29: 427–438

    Article  CAS  PubMed  Google Scholar 

  3. Ploemacher RE, van Soest PL, Voorwinden H, Boudewijn A . Interleukin-12 synergizes with interleukin-3 and steel factor to enhance recovery of murine hemopoietic stem cells in liquid culture Leukemia 1993 7: 1381–1388

    CAS  PubMed  Google Scholar 

  4. Bellone G, Trinchieri G . Dual stimulatory and inhibitory effect of NK cell stimulatory factor/IL-12 on human hematopoiesis J Immunol 1994 153: 930–937

    CAS  PubMed  Google Scholar 

  5. Inatomi Y, Toyama K, Clark SC, Shimizu K, Miyauchi J . Combinations of stem cell factor with other hematopoietic growth factors enhance growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia Cancer Res 1994 54: 445–462

    Google Scholar 

  6. Bruserud Φ, Gjertsen BT, Brustugun OT, Bassøe CF, Nesthus I, Akselsen PE, Bühring HJ, Pawelec G . Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia Leukemia 1995 9: 1910–1920

    CAS  PubMed  Google Scholar 

  7. Löwenberg B, Suciu S, Archimbaud E, Ossenkoppele G, Verhoef GE, Vellenga E, Wijermans P, Berneman Z, Dekker AW, Stryckmans P, Schouten H, Jehn U, Muus P, Sonneveld P, Dardenne M, Zittoun R . Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group Blood 1997 90: 2952–2961

    PubMed  Google Scholar 

  8. Witz F, Sadoun A, Perrin MC, Berthou C, Briere J, Cahn JY, Lioure B, Witz B, Francois S, Desablens B, Pignon B, Le Prise PY, Audhuy B, Caillot D, Casassus P, Delain M, Christian B, Tellier Z, Polin V, Hurteloup P, Harousseau JL . A placebo-controlled study of recombinant human granulocyte–macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucemies Aigues Myeloblastiques (GOELAM) Blood 1998 91: 2722–2730

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The author thanks Dr K Toyama, First Department of Internal Medicine, Tokyo Medical college, for providing patient samples and T Minegishi for assistance in cell culture.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miyauchi, J. In vitro effects of interleukin-12 on the growth of blast progenitors in acute myelogenous leukemia. Leukemia 15, 1996–1998 (2001). https://doi.org/10.1038/sj.leu.2402308

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402308

Search

Quick links